Back to
UBS Group AG
AEON6 quarters
Position history for
UBS Group AG's holdings in AEON BIOPHARMA INC
Yes. Ubs holds 5,062 shares of AEON (Aeon Biopharma), worth $3,640, as of its Q2 2026 13F filing. It increased the position by 880 shares (+21.0%) from Q1 2026. Ubs has held AEON since Q1 2025, across 6 quarterly 13F filings.
Current Value
$3,640
Current Shares
5,062
Total Value Change
+$1,925
Total Shares Change
+2,105
Quarter-by-Quarter History
Other major holders of AEON: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC